5JJ-25186-77497
2 vaccinations
1 coded response
18 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 770 / TX
- Registered
- 2021-01-28
- Relationship
- Self
- Race
- Native Hawaiian or other Pacific Islander
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-28
Registered in v-safe
-
2021-01-28
Dose 1 — Pfizer-BioNTech
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-02
- 2021-02-03
-
2021-02-04
Health check-in — day 7, dose 1Feeling: Good · Chills, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-04
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-02-11
- 2021-02-18
-
2021-02-27
Dose 2 — Pfizer-BioNTech
- 2021-02-27
-
2021-02-28
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: Good · Site: Pain · HeadacheFree text: Bruising at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-05
- 2021-03-06
- 2021-03-15
- 2021-03-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-28 | Pfizer-BioNTech | |
| 2 | 2021-02-27 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-04 | priority 2/3 |
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Bruising at injection site
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release